The World Health Organization (WHO) has issued its first-ever guidelines on the diagnosis and management of type 1 diabetes in adults, calling for improved access to affordable insulin and essential diabetes care.
Released as the World Diabetes Day 2026 is being observed globally, the guidelines seek to improve access to lifesaving insulin and quality care, including in low-resource settings.
In a statement, WHO targets to ensure that all people with type 1 diabetes have access to affordable insulin treatment and blood glucose self-monitoring by 2030.
Insulin Treatment
More than 100 years after the discovery of insulin, many people living with type 1 diabetes still cannot access the insulin and care they need to survive.
Type 1 diabetes is a lifelong condition in which the body does not produce enough insulin, making people dependent on daily insulin to survive.
In 2025, around 9.5 million people lived with type 1 diabetes globally, with an additional 500 000 diagnosed in the same year. While often considered primarily a childhood condition, type 1 diabetes is increasingly affecting adults.
“Insulin is a lifesaving treatment, discovered more than 100 years ago. Yet many people with type 1 diabetes do not have access to affordable and high-quality insulin,” said Dr Søren Brostrøm, WHO Director of Noncommunicable Diseases and Mental Health.